Baran Pharmaceutical

Baran Pharmaceutical Company, also known as Baran Darou, is a specialized pharmaceutical firm based in Iran that focuses on the development and production of high-tech active pharmaceutical ingredients (APIs) and finished dosage forms. The company is particularly recognized for its expertise in peptide synthesis and the manufacturing of potent cytotoxic drugs for oncology and endocrine disorders. Baran operates state-of-the-art facilities that comply with international Good Manufacturing Practice (GMP) standards, enabling the production of complex molecules like octreotide and leuprorelin. Their business model emphasizes import substitution and the provision of affordable, high-quality specialty medicines to the regional market. With a robust pipeline of generic high-tech products, Baran Pharmaceutical serves as a key player in the Middle Eastern biotechnology and pharmaceutical landscape.